Disease Info Card

Anaplastic Oligoastrocytoma

Information about Anaplastic Oligoastrocytoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Anaplastic Oligoastrocytoma

Most recent studies have shown that Anaplastic Oligoastrocytoma shares some biological mechanisms with anaplastic-astrocytoma, anaplastic-oligodendroglioma, astrocytoma, brain-neoplasms, cell-transformation-neoplastic, ependymoma, glioblastoma, glioblastoma-multiforme, glioma, malignant-glioma, malignant-neoplasms, malignant-paraganglionic-neoplasm, mixed-gliomas, mixed-oligodendroglioma-astrocytoma, neoplasm-recurrence-local, neoplasms, nervousness, oligodendroglioma, pilocytic-astrocytoma, tumor-progression.

Among the many pathways, these few ones have gauged particular interests from scientists studying Anaplastic Oligoastrocytoma, and have been seen in publications frequently: Angiogenesis, Cell Growth, Cell Motility, Dna Repair, Drug Resistance, Interphase, Methylation, Mismatch Repair, Oncogenesis, Pathogenesis

Quite a number of genes have been found to play important roles in Anaplastic Oligoastrocytoma, such as ADAMTS13, APTX, AR, CDKN2A, CDKN2B, EGFR, IDH1, LCN2, MGMT, MID1, PGR, POMT1, SH3BP4, TEAD1, TNF, TP53, ZFP36. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.